ArticleInternational urology and nephrology2026

Association of phosphodiesterase type 5 inhibitor use with cardiovascular and renal outcomes in male kidney transplant recipients with benign prostatic hyperplasia or erectile dysfunction.

Jan Yuan-Sheng Hsu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.